Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
Actual shortage: | 255 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
30 (12%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2021-09-23 | 2021-11-18 | 146112 |
ACT AMLODIPINE | 10MG | TABLET | Resolved | 2021-09-30 | 2021-10-07 | 146443 |
TEVA-CLOPIDOGREL | 75MG | TABLET | Resolved | 2021-09-30 | 2022-01-20 | 146446 |
TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2021-09-30 | 2021-11-11 | 146449 |
TEVA-ATORVASTATIN | 20MG | TABLET | Resolved | 2021-09-30 | 2021-11-11 | 146456 |
TEVA-FINASTERIDE | 5MG | TABLET | Resolved | 2021-09-30 | 2021-10-07 | 146459 |
TEVA-LEFLUNOMIDE | 20MG | TABLET | Resolved | 2021-09-30 | 2021-10-21 | 146462 |
TEVA-CEPHALEXIN | 250MG | TABLET | Resolved | 2021-09-30 | 2021-10-07 | 146466 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-09-30 | 2021-11-05 | 146469 |
TEVA-ATORVASTATIN | 10MG | TABLET | Resolved | 2021-10-07 | 2021-11-11 | 146847 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-10-07 | 2021-11-05 | 146856 |
TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2021-10-14 | 2021-12-17 | 147216 |
TEVA-ABACAVIR/LAMIVUDINE | 300MG 600MG | TABLET | Resolved | 2021-10-21 | 2021-12-17 | 147699 |
TEVA-CANDESARTAN/HCTZ | 12.5MG 16MG | TABLET | Resolved | 2021-10-21 | 2022-01-07 | 147702 |
TEVA-ATORVASTATIN | 40MG | TABLET | Resolved | 2021-10-21 | 2021-12-08 | 147705 |
TEVA-NAPROXEN SODIUM | 275MG | TABLET | Resolved | 2021-10-21 | 2021-11-05 | 147708 |
TEVA-RISEDRONATE | 30MG | TABLET | Resolved | 2021-10-21 | 2021-12-17 | 147714 |
TEVA-CODEINE | 30MG | TABLET | Resolved | 2021-11-04 | 2022-03-09 | 148838 |
TEVA-MELOXICAM | 7.5MG | TABLET | Resolved | 2021-11-04 | 2021-11-11 | 148841 |
TEVA-FAMOTIDINE | 20MG | TABLET | Resolved | 2021-11-11 | 2022-01-07 | 149105 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-AMLODIPINE | 5MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 120036 |
TEVA-AMLODIPINE | 10MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 120039 |
TEVA-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2020-09-24 | 2020-09-24 | 124896 |
TEVA-CEPHALEXIN | 250MG | TABLET | Discontinued | 2020-10-08 | 2020-10-09 | 125982 |
TEVA-AMITRIPTYLINE | 50MG | TABLET | Discontinued | 2020-10-22 | 2020-10-24 | 126900 |
TEVA-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2020-10-22 | 2020-10-24 | 126903 |
TEVA-LOSARTAN/HCTZ | 100MG 12.5MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133896 |
TEVA-LOSARTAN/HCTZ | 100MG 25MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133899 |
TEVA-LOSARTAN/HCTZ | 50.0MG 12.5MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133902 |
TEVA-RISEDRONATE | 150MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133905 |
TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133908 |
ACT RIZATRIPTAN | 10MG | TABLET | Discontinued | 2021-07-22 | 2021-07-22 | 142912 |
TEVA-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2022-01-07 | 2022-01-07 | 152351 |
TEVA-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2022-01-07 | 2022-01-07 | 152375 |
TEVA-AMITRIPTYLINE | 50MG | TABLET | Discontinued | 2022-01-07 | 2022-01-07 | 152378 |
TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
TEVA-IRBESARTAN | 75MG | TABLET | Discontinued | 2024-04-01 | 2024-04-01 | 224049 |